Lung cancer trials in Vietnam

In Vietnam 15 Also abroad 2733

15 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Where
Hanoi, Ho Chi Minh City, Vinh
Age
18 years and over
People
400 worldwide
Run by
AstraZeneca
See details and how to joinNCT07291037 · EU 2024-520101-39-00
Phase 3Taking people
DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
Where
Hanoi, Ho Chi Minh City
Age
18 years and over
People
670 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT07472517 · EU 2025-520565-51-00
Phase 3Taking people
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
Where
Hanoi, Hà Nội, Ho Chi Minh, Ho Chi Minh City
Age
18 years and over
People
614 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06170788 · EU 2023-503376-24-00
Phase 2Taking people
Osimertinib Plus Stereotactic Radiosurgery/Radiotherapy for EGFR-Mutant Non-Small Cell Lung Cancer With Symptomatic Brain Metastases
Where
Ho Chi Minh City
Age
18 years and over
People
41
Run by
Cho Ray Hospital
See details and how to joinNCT07911449
Phase 3Taking people
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Where
Can Tho, Hanoi, Ho Chi Minh City, Vinh
Age
18 years and over
People
1,160 worldwide
Run by
AstraZeneca
See details and how to joinNCT06692738 · EU 2024-514281-39-00
Phase 3Taking people
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Where
Da Nang, Hanoi, Hà Nội, Ho Chi Minh City, Huế, Vinh, Vĩnh Yên
Age
18 years and over
People
675 worldwide
Run by
AstraZeneca
See details and how to joinNCT06357533 · EU 2023-505077-32-00
Phase 3Taking people
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC
Where
Can Tho, Hanoi, Ho Chi Minh City, Vinh
Age
18 years and over
People
1,160 worldwide
Run by
AstraZeneca
See details and how to joinNCT06627647 · EU 2024-515008-38-00
No phaseTaking people
ENPP1/cGAS (EG) and FAP Expression Profiles in Solid Tumors: An Immunohistochemical Study in a Vietnamese Cohort
Where
Hanoi, Ho Chi Minh City
Age
18 years and over
People
162
Run by
Tam Anh Research Institute
See details and how to joinNCT07808164
No phaseTaking people
Intermittent Erector Spinae Plane Block Via Subcutaneous Port for Cancer Pain
Where
Hanoi
Age
18 years and over
People
180
Run by
Hanoi Medical University
See details and how to joinNCT07396558
No phaseTaking people
Effectiveness of Chat-based Mobile Application for Consultation (Zalo) in Improving Compliance With Follow-up Tests After Abnormal Chest X-ray Findings Interpret by Artificial Intelligent
Where
Ho Chi Minh City
Age
40 years to 62 years
People
2,692
Run by
Gia Dinh People Hospital
See details and how to joinNCT07234929
Phase 3Taking people
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Where
Hanoi, Hà Nội, Ho Chi Minh City, Vinh
Age
18 years and over
People
582 worldwide
Run by
AstraZeneca
See details and how to joinNCT06350097 · EU 2023-509883-89-00
No phaseTaking people
Analysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic Cancer.
Where
Ho Chi Minh City
Age
18 years to 80 years
People
50
Run by
Gene Solutions
See details and how to joinNCT06227728
No phaseNot yet taking people in Vietnam
Validation of the SPOT-MAS Lung Test Using Circulating Tumor DNA for the Detection of Lung Cancer
Where
Ho Chi Minh City
Age
50 years to 80 years
People
1,184
Run by
Gene Solutions
See details and how to joinNCT07126626
No phaseTaking people
Analysis of Circulating Tumor DNA Dynamics to Predict and Monitor Response to TKI in Patients With Advanced NSCLC.
Where
Ho Chi Minh City
Age
18 years to 80 years
People
50
Run by
Gene Solutions
See details and how to joinNCT06167460
No phaseEnrolling by invitation
Clinical Validation of an MCED Test in Symptomatic Populations (K-ACCELERATE)
Where
Ho Chi Minh City
Age
18 years and over
People
1,000
Run by
Gene Solutions
See details and how to joinNCT06391749